• Sign In
  • Register
  • Glossary
  • Share/Bookmark
  • RSS
All About Bleeding

References for Inherited Bleeding Disorders

1. Kreuz W, Meili E, Peter-Salonen K, Dobrkovska A, Devay J, Haertel S, et al. Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfus Apher Sci 2005;32(3):239-46.

2. Tortora GJ, Derrickson B. The Cardiovascular System: The Blood. Principles of Anatomy and Phsyiology. 11th ed: John Wiley & Sons Inc., 2006:666–94.

3. Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost 2006;4(10):2115-29.

4. Agarwal MB, Sanzgiri PS, Bhanotra PC, Rao S, Mehta BC, Shah MD. Congenital disorders of fibrinogen. J postgrad Med 1981;27(3):178-83.

5. Danes AF, Cuenca LG, Bueno SR, Mendarte Barrenechea L, Ronsano JB. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 2008;94(3):221-6.

6. Israels SJ. Inherited Abnormalities of Fibrinogen. emedicine.medscape.com, 2009.

7. Peyvandi F, Haertel S, Knaub S, Mannucci PM. Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia. J Thromb Haemost 2006;4(7):1634-7.

8. Craig J, Agular-Ilbanez R, Bhattacharya S, Downie S, Duffy S, Kohli H, et al. The clinical and cost effectiveness of thromboelastography/thromboelastometry. Glasgow: NHS Quality Improvement Scotland, 2008.

9. Okuda M, Uemura Y, Tatsumi N, Honda S. Proposed fibrinogen standard material with purified fibrinogen for plasma fibrinogen measurement on coagulation analyser. J Autom Methods Manag Chem 2003;25(5):103-7.

10. Mackie IJ, Kitchen S, Machin SJ, Lowe GD. Guidelines on fibrinogen assays. Br J Haematol 2003;121(3):396-404.

11. Fenger-Eriksen C, Ingerslev J, Sorensen B. Fibrinogen concentrate--a potential universal hemostatic agent. Expert Opin Biol Ther 2009;9(10):1325-33.

12. Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Sorensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010;50(12):2571-6.

13. Bevan DH. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders? Thromb Res 2009;124 Suppl 2:S12-16.

14. Peyvandi F. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency. Thrombosis Research 2009;124:S9-S11.

15. Dickneite G, Pragst I, Joch C, Bergman GE. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 2009;20(7):535-40.

16. Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004;125(1):69-73.

17. Hoffbrand AV, Moss PAH, Pettit JE. Platelets, blood coagulation and haemostasis. Essential Haematology. 5th ed: Blackwell Publishing, Inc., 2009:264–77.

18. Schwartz RA, Klujszo E, Gascon P, McKenna R. Factor XIII. emedicine: Medscape, 2010.

19. Hartung H. Factor XIII Deficiency. emedicine Specialties: Medscape, 2010.

20. Clancy JC, McVicar AJ. The cardiovascular system 1: blood. Physiology & Anatomy: A Homeostatic Approach. 2nd ed: Arnold Publishers, 2002:278–315.

21. Harrison P. Tests of platelet function. In: Key N, Makris M, O'Shaughnessy D, Lillicrap D, editors. Practical Hemostasis and Thrombosis. 2nd ed: Wiley-Blackwell, 2009:37–47.

22. Shuman M. Hemorrhagic disorders: abnormalities of platelet and vascular functions. In: Goldman L, Ausiello D, editors. Cecil Textbook of Medicine. 22nd ed: Saunders, 2004:1060-69.

23. Castaman G, Tosetto A, Rodeghiero F. Von Willebrand disease. In: Key N, Makris M, O'Shaughnessy D, Lillicrap D, editors. Practical Hemostasis and Thrombosis. Second ed: Wiley-Blackwell, 2009:73-87.

24. George JN. Thrombocytopenia and Platelet Dysfunction. Merck Manual: Merck Sharp & Dohme Corp., 2009. 25. Thiagarajan P. Platelet Disorders. emedicine: Netscape, 2009.

26. Ma A. Evaluation of the bleeding patient. In: Key N, Makris M, O'Shaughnessy D, Lillicrap D, editors. Practical Hemostasis and Thrombosis. 2nd ed: Wiley-Blackwell, 2009:48–60.

27. Sarode R. Blood Products. The Merck Manuals Online Medical Library: Merck Sharp and Dohme Corp., 2006.

28. Meyer, M. Molekularbiologie der Gerinnung: Fibrinogen, Faktor XIII, Hämostaseologie 2, 2004:108-115.

29. Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia 2008;14:1190-1200.


Last Updated: 10/31/2014 4:15 PM
  • E-mail
  • Print
  • Share